Wegovy and Acetaminophen Interaction: What Patients Need to Know
Clinical breakdown of the Wegovy (semaglutide 2.4 mg) and acetaminophen interaction, including pharmacokinetic data, FDA label guidance, hepatic safety, and practical dosing advice.
WEGOVY: Drug Interactions
29 source-based articles maintained by the HealthRX.com Editorial Team.
29articles
3topic areas covered
May 26, 2026latest review
WEGOVY: Drug Interactions library
Showing 29 of 29 clinical reviews.
Wegovy and Apixaban Interaction: Safety, Monitoring, and Clinical Evidence
Board-reviewed guide on taking Wegovy (semaglutide 2.4 mg) with apixaban (Eliquis). Covers pharmacokinetic mechanisms, severity rating, dose adjustments, and monitoring recommendations.
Wegovy and Atorvastatin Interaction: Safety, Monitoring, and Clinical Evidence
Can you take Wegovy (semaglutide 2.4 mg) with atorvastatin? A guide covering pharmacokinetic data, safety evidence, monitoring recommendations, and dose-adjustment guidance.
Wegovy and Benzodiazepines Interaction: What Patients and Prescribers Need to Know
A clinical review of the pharmacokinetic and pharmacodynamic interactions between semaglutide 2.4 mg (Wegovy) and benzodiazepines, including monitoring guidance, dose considerations, and patient counseling points.
Wegovy and Bupropion Interaction: What Patients and Prescribers Need to Know
A guide to the semaglutide 2.4 mg and bupropion drug interaction, covering mechanism, seizure risk, monitoring protocols, and dose-adjustment guidance.
Wegovy and Clopidogrel Interaction: What Patients and Prescribers Need to Know
A guide to the pharmacokinetic and pharmacodynamic interaction between semaglutide 2.4 mg (Wegovy) and clopidogrel, including mechanism, severity, monitoring parameters, and patient counseling.
Wegovy and Diphenhydramine Interaction: Safety, Risks, and Clinical Guidance
Can you take Wegovy (semaglutide 2.4 mg) with diphenhydramine? A guide covering pharmacokinetic and pharmacodynamic interactions, monitoring parameters, and patient counseling.
Wegovy and Estradiol HRT Interaction: Safety, Risks, and Clinical Guidance
Is it safe to take Wegovy (semaglutide 2.4 mg) with estradiol hormone replacement therapy? Review the pharmacokinetic and pharmacodynamic interactions, VTE risk overlap, monitoring protocols, and dose-adjustment considerations.
Wegovy and Finasteride Interaction: What Patients and Clinicians Need to Know
A clinical evidence review of the pharmacokinetic and pharmacodynamic considerations between semaglutide 2.4 mg (Wegovy) and finasteride, including what is established, what is plausible but unproven, and what should be verified before assuming the combination is risk-free.
Wegovy and Gabapentin Interaction: What Patients and Prescribers Need to Know
A clinical deep-dive into the semaglutide 2.4 mg and gabapentin drug interaction, covering pharmacokinetic mechanisms, CNS sedation overlap, renal considerations, monitoring parameters, and patient counseling points.
Wegovy and Hormonal Contraceptives: What the Interaction Data Actually Show
A guide to the interaction between semaglutide 2.4 mg (Wegovy) and hormonal contraceptives, covering mechanism, absorption risk, monitoring, and patient counseling for women on combined therapy.
Wegovy and Levothyroxine Interaction: What Patients and Prescribers Need to Know
Clinical guide to the Wegovy (semaglutide 2.4 mg) and levothyroxine drug interaction, covering absorption delay mechanisms, TSH monitoring protocols, dose-adjustment strategies, and patient counseling.
Wegovy and Metformin Interaction: What Patients and Clinicians Need to Know
A guide to the Wegovy (semaglutide 2.4 mg) and metformin drug interaction: mechanism, safety evidence, monitoring parameters, and patient counseling.
Wegovy and NSAIDs (Ibuprofen, Naproxen): What the Interaction Actually Means for You
A deep dive into the semaglutide 2.4 mg and NSAID interaction: GI bleeding risk, renal effects, gastric-emptying pharmacokinetics, and exact monitoring steps for patients on Wegovy.
Wegovy and Opioids (Oxycodone, Hydrocodone, Tramadol): Interaction Risk, Safety, and Monitoring
Clinical guide to the Wegovy (semaglutide 2.4 mg) and opioid interaction. Covers delayed gastric emptying, aspiration risk under anesthesia, respiratory depression overlap, dose timing, and monitoring for patients on oxycodone, hydrocodone, or tramadol.
Wegovy and PPIs (Omeprazole, Pantoprazole): Drug Interaction Guide
Clinical review of the interaction between Wegovy (semaglutide 2.4 mg) and proton pump inhibitors like omeprazole and pantoprazole, including mechanism, safety data, monitoring, and dose adjustment guidance.
Wegovy and Prednisone Interaction: Safety, Risks, and Clinical Guidance
Can you take Wegovy (semaglutide 2.4 mg) with prednisone? Learn about the pharmacodynamic interaction, blood sugar effects, bone density risks, monitoring protocols, and dose adjustment strategies.
Wegovy and Pregabalin Interaction: What Patients and Prescribers Need to Know
A clinical deep-dive into the semaglutide 2.4 mg and pregabalin drug interaction: pharmacokinetic mechanisms, pharmacodynamic risks, monitoring parameters, dose considerations, and patient counseling points backed by primary literature.
Wegovy and Progesterone HRT Interaction: What Patients and Clinicians Need to Know
A review of the pharmacokinetic and pharmacodynamic considerations when semaglutide 2.4 mg (Wegovy) is used alongside progesterone hormone therapy, including mechanism, evidence gaps, monitoring points, and questions to raise with a prescriber.
Wegovy and Rivaroxaban Interaction: What the Evidence Actually Shows
Board-reviewed analysis of the Wegovy (semaglutide 2.4 mg) and rivaroxaban drug interaction, covering pharmacokinetic mechanisms, clinical significance, monitoring parameters, and prescriber guidance.
Wegovy and Sildenafil Interaction: What You Need to Know
A guide to the semaglutide 2.4 mg and sildenafil drug interaction, covering mechanism, hypotension risk, monitoring parameters, and patient counseling for men on both medications.
Wegovy and Simvastatin Interaction: Safety, Monitoring, and What the Evidence Shows
Board-reviewed analysis of the Wegovy (semaglutide 2.4 mg) and simvastatin drug interaction, covering pharmacokinetic mechanisms, clinical evidence, monitoring guidance, and dose-adjustment considerations.
Wegovy and SNRIs (Venlafaxine, Duloxetine): Drug Interaction Guide
A clinician-level review of combining semaglutide 2.4 mg (Wegovy) with SNRIs such as venlafaxine and duloxetine. Covers pharmacokinetic and pharmacodynamic mechanisms, serotonin syndrome risk, blood pressure monitoring, and dose-adjustment guidance.
Wegovy and SSRIs (Sertraline, Escitalopram): Drug Interaction Guide
Can you take Wegovy with sertraline or escitalopram? A clinician-level review of semaglutide 2.4 mg and SSRI interactions covering mechanism, serotonin risk, GI effects, absorption changes, monitoring, and dose adjustment.
Wegovy and Tadalafil Interaction: What Patients and Prescribers Need to Know
A clinical deep-dive into the semaglutide 2.4 mg and tadalafil drug interaction, covering mechanism, hypotension risk, monitoring parameters, and practical prescribing guidance.
Wegovy and Testosterone Interaction: What Patients and Clinicians Need to Know
A guide to the semaglutide 2.4 mg and testosterone drug interaction, covering mechanism, monitoring, dose adjustment, and patient counseling with primary-source citations.
Wegovy and Trazodone Interaction: Safety, Risks, and Clinical Guidance
Can you take Wegovy (semaglutide 2.4 mg) with trazodone? A guide covering pharmacokinetic and pharmacodynamic interactions, monitoring parameters, dose adjustments, and patient counseling.
Wegovy and Warfarin Interaction: What Patients and Prescribers Need to Know
Clinical guide to the Wegovy (semaglutide 2.4 mg) and warfarin interaction, covering mechanism, INR monitoring, dose adjustment, and safety data from trials and FDA labeling.
Wegovy and Zolpidem Interaction: What Clinicians and Patients Should Know
A clinical review of the Wegovy (semaglutide 2.4 mg) and zolpidem interaction, covering mechanism, evidence strength, monitoring, and patient counseling.